- Home
- PTLO vs KMDA Comparison
PTLO vs KMDA Comparison
Compare PTLO & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTLO
- KMDA
- Stock Information
- Founded
- PTLO 1963
- KMDA 1990
- Country
- PTLO United States
- KMDA Israel
- Employees
- PTLO N/A
- KMDA N/A
- Industry
- PTLO Restaurants
- KMDA Biotechnology: Pharmaceutical Preparations
- Sector
- PTLO Consumer Discretionary
- KMDA Health Care
- Exchange
- PTLO Nasdaq
- KMDA Nasdaq
- Market Cap
- PTLO 490.4M
- KMDA 410.6M
- IPO Year
- PTLO 2021
- KMDA N/A
- Fundamental
- Price
- PTLO $6.45
- KMDA $6.92
- Analyst Decision
- PTLO Buy
- KMDA Strong Buy
- Analyst Count
- PTLO 8
- KMDA 2
- Target Price
- PTLO $12.19
- KMDA $13.00
- AVG Volume (30 Days)
- PTLO 3.5M
- KMDA 47.6K
- Earning Date
- PTLO 11-04-2025
- KMDA 11-12-2025
- Dividend Yield
- PTLO N/A
- KMDA 2.84%
- EPS Growth
- PTLO 17.90
- KMDA 27.97
- EPS
- PTLO 0.46
- KMDA 0.32
- Revenue
- PTLO $727,754,000.00
- KMDA $169,517,000.00
- Revenue This Year
- PTLO $6.74
- KMDA $14.49
- Revenue Next Year
- PTLO $10.15
- KMDA $10.12
- P/E Ratio
- PTLO $13.60
- KMDA $21.23
- Revenue Growth
- PTLO 3.62
- KMDA 9.67
- 52 Week Low
- PTLO $6.00
- KMDA $5.17
- 52 Week High
- PTLO $15.78
- KMDA $9.16
- Technical
- Relative Strength Index (RSI)
- PTLO 33.73
- KMDA 43.12
- Support Level
- PTLO $6.02
- KMDA $6.80
- Resistance Level
- PTLO $6.29
- KMDA $7.15
- Average True Range (ATR)
- PTLO 0.23
- KMDA 0.19
- MACD
- PTLO 0.07
- KMDA -0.00
- Stochastic Oscillator
- PTLO 39.59
- KMDA 19.05
About PTLO Portillo's Inc.
Portillos Inc serves the Chicago street food industry through high-energy and multichannel restaurants designed to ignite the senses and create memorable dining experiences. It owns and operates fast-casual restaurants in the United States, along with two food production commissaries in Illinois. Its menu includes hot dogs, beef and sausage sandwiches, sandwiches and ribs, salads, burgers, chicken, Barnelli's pasta, sides and soup, and desserts and shakes.
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.